Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.77 |
| ▸ | NSD2 | O96028 | 1/20 | 0.77 |
| ▸ | TDO2 | P48775 | 1/20 | 0.77 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.67 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.67 |
| ▸ | RECQL | P46063 | 2/20 | 0.67 |
| ▸ | MAPT | P10636 | 2/20 | 0.67 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.67 |
| ▸ | SOST | Q9BQB4 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | GAA | P10253 | 2/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.67 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.67 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.67 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fustin SCHEMBL13640269 | 1.00 | IDO1 (0.77) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Fustin SCHEMBL29929489 | 1.00 | IDO1 (0.77) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Fustin SCHEMBL13583362 | 1.00 | IDO1 (0.77) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Fustin SCHEMBL30443589 | 1.00 | IDO1 (0.77) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| SCHEMBL12378836 | 0.89 | IDO1 (0.77) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| SCHEMBL12417567 | 0.89 | IDO1 (0.77) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Garbanzol SCHEMBL29370332 | 0.88 | ESR1 (0.73) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Garbanzol SCHEMBL9663852 | 0.88 | ESR1 (0.73) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Garbanzol SCHEMBL29929200 | 0.88 | ESR1 (0.73) | IDO1NSD2TDO2KDM4ECYP3A4 | |
| Dihydrobinetin SCHEMBL18177341 | 0.87 | SYNJ2 (0.64) | IDO1NSD2TDO2KDM4ECYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 804 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4580594-A1 | ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS | AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) | 2025-07-09 | — | — | EP | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2024046834-A1 | ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS | ANALYTICON DISCOVERY GMBH (DE) | 2024-03-07 | — | — | WO | claimed |
| EP-4331564-A1 | ANTIOXIDANT COMPOSITION COMPRISING 5-DEOXYFLAVONOIDS | Analyticon Discovery GmbH (DE) | 2024-03-06 | — | — | EP | claimed |
| CN-112888449-B | Preparation method of Rhus verniciflua Stokes extract with increased fisetin content, and anticancer agent composition for metastasis inhibition comprising the same | 麦蒂恩斯株式会社 | 2023-04-07 | — | — | CN | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| CN-115300640-A | Novel linkers and their use for specific coupling of drugs and biomolecules | 杭州多禧生物科技有限公司 | 2022-11-08 | — | — | CN | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| CN-108289964-B | Novel linkers and their use for specific coupling of drugs and biomolecules | 杭州多禧生物科技有限公司 | 2022-08-12 | — | — | CN | claimed |
| WO-1998041688-A1 | SECURITY PAPER | GEORGIA-PACIFIC CORPORATION, INC. (US) | 1998-09-24 | — | — | WO | claimed |
| EP-0804815-A4 | SOLID STATE ELECTROCHEMICAL CELL CONTAINING A PROTON-DONATING AROMATIC COMPOUND | ELECTRO CHEM RES (IL) | 1998-08-26 | — | — | EP | claimed |
| US-5731105-A | Battery electrochemical cell with a non-liquid electrolyte | E.C.R. - ELECTRO-CHEMICAL RESEARCH LTD. (IL) | 1998-03-24 | — | — | US | claimed |
| EP-0804815-A1 | SOLID STATE ELECTROCHEMICAL CELL CONTAINING A PROTON-DONATING AROMATIC COMPOUND | E.C.R. - ELECTRO-CHEMICAL RESEARCH LTD. (IL) | 1997-11-05 | — | — | EP | claimed |
| US-5580681-A | SOLID ELECTROLYTE, ORGANIC ANODE, SOLID CATHODE | E.C.R.-ELECTRO-CHEMICAL RESEARCH LTD. (IL) | 1996-12-03 | — | — | US | claimed |
| EP-0719554-A1 | Chondroprotective flavonoids | Kureha Chemical Industry Co., Ltd. (JP) | 1996-07-03 | — | — | EP | claimed |
| US-5512391-A | SUITABLE FOR ELECTRONIC CONSUMER PRODUCTS, BIOMEDICAL APPLICATIONS, ELECTRIC VEHICLE APPLICATIONS | E.C.R. - ELECTRO-CHEMICAL RESEARCH LTD. (IL) | 1996-04-30 | — | — | US | claimed |
| WO-1995007555-A1 | SOLID STATE ELECTROCHEMICAL CELL CONTAINING A PROTON-DONATING AROMATIC COMPOUND | E.C.R. - ELECTRO-CHEMICAL RESEARCH LTD. (IL) | 1995-03-16 | — | — | WO | claimed |
| US-5382481-A | Battery has anode with donor aromatic compound, cathode with acceptor compound, and electrolyte; reversible; electronics | E.C.R.-ELECTRO-CHEMICAL RESEARCH LTD. (IL) | 1995-01-17 | — | — | US | claimed |
| EP-0633022-A2 | Chondroprotective flavones | KUREHA CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-01-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | IDO1 4638/4885NSD2 4635/4885TDO2 4413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.